SCHEMBL3852832

SCHEMBL3852832

COc1ccc(CN2CCN(c3ncnc4ccc(-c5c[nH]nc5C)cc34)CC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.55
BACE1 P56817 4/20 0.55
AURKA O14965 1/20 0.52
TNF P01375 1/20 0.49
NOD1 Q9Y239 1/20 0.49
CYP1A2 P05177 6/20 0.48
CYP3A4 P08684 6/20 0.48
ALDH1A1 P00352 6/20 0.48
CYP2C19 P33261 5/20 0.48
USP2 O75604 5/20 0.48
CLK4 Q9HAZ1 5/20 0.48
LMNA P02545 5/20 0.48
HIF1A Q16665 4/20 0.48
MAPK1 P28482 4/20 0.48
CYP2D6 P10635 3/20 0.48
ATM Q13315 1/20 0.48
MEN1 O00255 5/20 0.48
KMT2A Q03164 4/20 0.48
TSHR P16473 3/20 0.48
KDM4E B2RXH2 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3847428 0.90 ACHE (0.58) ACHEBACE1AURKACYP1A2CYP3A4
SCHEMBL3856383 0.84 HTT (0.65) ACHEBACE1CYP1A2CYP3A4ALDH1A1
SCHEMBL3854138 0.83 AKT1 (0.56) ACHEBACE1AURKATNFNOD1
SCHEMBL3851339 0.81 CYP3A4 (0.67) ACHEBACE1CYP1A2CYP3A4ALDH1A1
SCHEMBL3846275 0.81 HTT (0.50) ACHEBACE1AURKACYP1A2CYP3A4
SCHEMBL3854867 0.81 AURKA (0.60) ACHEBACE1AURKACYP1A2CYP3A4
SCHEMBL3846032 0.80 HTT (0.52) ACHEBACE1AURKATNFNOD1
SCHEMBL3847066 0.78 CYP1A2 (0.61) CYP1A2CYP3A4ALDH1A1CYP2C19USP2
SCHEMBL3877387 0.78 CYP1A2 (0.52) CYP1A2CYP3A4ALDH1A1CYP2C19USP2
SCHEMBL3846990 0.76 ACHE (0.54) ACHEBACE1AURKACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed